AFMD
Affimed NV
NASDAQ · Healthcare · Biotechnology · DE
$0.18
+0.00%Latest reported
- Last report date
- Jun 11, 2025
- EPS actual
- -$1.38
- EPS estimate
- -$0.52
- Revenue actual
- —
- Revenue estimate
- $118.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -40.1%
- Revenue beats (12Q)
- 4
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jun 11, 2025 | -$0.52 | -$1.38 | Miss -165.38% | — |
| Mar 27, 2025 | -$0.91 | -$0.87 | Beat 4.44% | $207.0K |
| Nov 14, 2024 | -$1.14 | -$1.03 | Beat 9.65% | $170.0K |
| Sep 5, 2024 | -$1.00 | -$1.09 | Miss -9.00% | $165.6K |
| Jun 12, 2024 | -$1.73 | -$1.38 | Beat 20.23% | $166.5K |
| Nov 14, 2023 | -$2.10 | -$1.70 | Beat 19.05% | $2.1M |
| Aug 10, 2023 | -$2.20 | -$2.20 | In line | $1.5M |
| May 23, 2023 | -$2.20 | -$2.30 | Miss -4.55% | $4.9M |
| Mar 23, 2023 | -$1.90 | -$2.20 | Miss -15.79% | $12.0M |
| Nov 15, 2022 | -$1.90 | -$1.10 | Beat 42.11% | $14.5M |
| Aug 11, 2022 | -$1.80 | -$1.40 | Beat 22.22% | $7.6M |
| Jun 1, 2022 | -$1.80 | -$1.60 | Beat 11.11% | $8.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2025